Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China flag China · Delayed Price · Currency is CNY
8.29
-0.07 (-0.84%)
Nov 6, 2026, 3:00 PM CST

SHA:600420 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
7,8839,21810,77011,78712,81013,756
Other Revenue
145.01145.01167.77282.98149.79189.06
8,0289,36310,93812,07012,95913,945
Revenue Growth
-13.35%-14.39%-9.38%-6.86%-7.07%11.06%
Cost of Revenue
5,7826,4386,8227,5388,0917,909
Gross Profit
2,2462,9254,1164,5324,8686,036
Selling, General & Admin
1,2511,2801,9212,9063,4144,220
Research & Development
364.63437.58565.65562.24517.14584.97
Other Operating Expenses
49.9678.1278.8899113.17128.31
Operating Expenses
1,6691,8122,5633,5494,0274,958
Operating Income
577.171,1141,553983.4841.241,078
Interest Expense
-1.7-4.39-36.89-57.88-107.31-110.47
Interest & Investment Income
168.25177.49151.08136.4861.6948.84
Currency Exchange Gain (Loss)
2.292.2940.6128.4498.32-32.65
Other Non Operating Income (Expenses)
-62.64-2.31-2.01-4.09-4.23-5.75
EBT Excluding Unusual Items
683.371,2871,7051,086889.71978
Impairment of Goodwill
------132.15
Gain (Loss) on Sale of Investments
------24.04
Gain (Loss) on Sale of Assets
-2.31-2.65-31.31-31.85-1.10.2
Asset Writedown
-21.57-32.79-28.26-13.13-4.93-10.81
Other Unusual Items
76.1976.1927.3355.19100.45107
Pretax Income
735.681,3281,6731,097984.12918.21
Income Tax Expense
96.2185.42340.97131.95116.6397.06
Earnings From Continuing Operations
639.481,1421,332964.61867.48821.15
Minority Interest in Earnings
-188.07-200.56-248.46-272.73-239.69-252.87
Net Income
451.41941.61,084691.88627.79568.28
Net Income to Common
451.41941.61,084691.88627.79568.28
Net Income Growth
-51.48%-13.11%56.62%10.21%10.47%-12.41%
Shares Outstanding (Basic)
1,3411,3411,3411,2731,0271,027
Shares Outstanding (Diluted)
1,3411,3411,3411,2731,1561,178
Shares Change
0.00%-5.31%10.13%-1.82%-0.14%
EPS (Basic)
0.340.700.810.540.610.55
EPS (Diluted)
0.340.700.810.540.540.48
EPS Growth
-51.48%-13.11%48.72%0.07%12.52%-12.29%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
423.041,4342,0361,3632,5481,158
Free Cash Flow Per Share
0.321.071.521.072.200.98
Dividend Per Share
0.2500.3000.3000.1000.1000.100
Dividend Growth
-16.67%0%200.00%0%0%0%
Gross Margin
27.98%31.25%37.63%37.55%37.57%43.28%
Operating Margin
7.19%11.89%14.19%8.15%6.49%7.73%
Profit Margin
5.62%10.06%9.91%5.73%4.84%4.08%
Free Cash Flow Margin
5.27%15.32%18.62%11.29%19.66%8.31%
EBITDA
1,2201,8122,3251,8021,6711,857
EBITDA Margin
15.20%19.36%21.25%14.93%12.90%13.31%
D&A For EBITDA
643.29698.59772.32818.89830.01778.52
EBIT
577.171,1141,553983.4841.241,078
EBIT Margin
7.19%11.89%14.19%8.15%6.49%7.73%
Effective Tax Rate
13.08%13.97%20.38%12.03%11.85%10.57%
Revenue as Reported
8,0289,36310,93812,07012,95913,945
Advertising Expenses
-4.696.184.643.297.1